Detalles de la búsqueda
1.
Lenograstim 5 µg/kg is not superior to biosimilar filgrastim 10 µg/kg in lymphoma patients undergoing peripheral blood stem cell mobilization after chemotherapy: preliminary results from a prospective randomized study.
Transfusion
; 58(5): 1143-1148, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29446445
2.
Establishment of reference values based on influential characteristics of hematopoietic stem cells and immune cell subsets in the bone marrow.
Heliyon
; 10(9): e30888, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38774070
3.
Adoptive immunotherapy with cytokine-induced killer cells generated with a new good manufacturing practice-grade protocol.
Cytotherapy
; 14(7): 841-50, 2012 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-22563888
4.
Poor mobilizer: a retrospective study on proven and predicted incidence according to GITMO criteria.
Transfus Apher Sci
; 47(2): 217-21, 2012 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-22784631
5.
Initial Results of Peripheral-Blood Stem-Cell Mobilization, Collection, Cryopreservation, and Engraftment After Autologous Transplantation Confirm That the Capacity-Building Approach Offers Good Chances of Success in Critical Contexts: A Kurdish-Italian Cooperative Project at the Hiwa Cancer Hospital, Sulaymaniyah.
J Glob Oncol
; (4): 1-8, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29244631
6.
The Start-Up of the first Hematopoietic Stem Cell Transplantation Center in the Iraqi Kurdistan: a Capacity-Building Cooperative Project by the Hiwa Cancer Hospital, Sulaymaniyah, and the Italian Agency for Development Cooperation: an Innovative Approach.
Mediterr J Hematol Infect Dis
; 9(1): e2017031, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28512560
7.
Biosimilar filgrastim (Zarzio®) vs. lenograstim (Myelostim®) for peripheral blood stem cell mobilization in adult patients with lymphoma and myeloma: a single center experience.
Leuk Lymphoma
; 57(2): 489-492, 2016 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-26099572
Resultados
1 -
7
de 7
1
Próxima >
>>